Wave Life Sciences is a clinical stage genetic medicine company. The Company is utilizing its synthetic chemistry platform to design and develop nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, with a goal of delivering new and exceptional treatment options for patients. Wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi, potentially enabling it to address a broad range of therapeutic areas and diseases.

Type
Public
HQ
Cambridge, US
Founded
2012
Size (employees)
96 (est)+135%
Wave Life Sciences was founded in 2012 and is headquartered in Cambridge, US
Report incorrect company information

Wave Life Sciences Office Locations

Wave Life Sciences has an office in Cambridge
Cambridge, US (HQ)
733 Concord Ave
Show all (1)
Report incorrect company information

Wave Life Sciences Financials and Metrics

Wave Life Sciences Financials

Wave Life Sciences's revenue was reported to be $3.70 m in FY, 2017
USD

Revenue (FY, 2017)

3.7 m

Net income (FY, 2017)

(102 m)

EBIT (FY, 2017)

(102.6 m)

Market capitalization (20-Apr-2018)

1.2 b

Cash (31-Dec-2017)

142.5 m
Wave Life Sciences's current market capitalization is $1.2 b.
Annual
USDFY, 2015FY, 2016FY, 2017

Revenue

152 k1.5 m3.7 m

Revenue growth, %

877%

General and administrative expense

10.4 m16 m27 m

R&D expense

9.1 m40.8 m79.3 m
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

152 k26 k417 k392 k

General and administrative expense

2.9 m3.2 m3.7 m3.9 m

R&D expense

2.1 m4.7 m8.4 m13.7 m

Operating expense total

5 m8 m12.1 m17.6 m
Annual
USDFY, 2015FY, 2016FY, 2017

Cash

161.2 m150.3 m142.5 m

Accounts Receivable

200 k

Inventories

146 k1.5 m

Current Assets

161.4 m152 m150.5 m
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016

Cash

66 m153.4 m181.8 m169 m

Accounts Receivable

200 k2.5 m

Current Assets

68 m154 m183.9 m172.1 m

PP&E

2 m3.2 m5.1 m6.7 m
Annual
USDFY, 2015FY, 2016FY, 2017

Net Income

(19.2 m)(55.4 m)(102 m)

Depreciation and Amortization

594 k784 k2.2 m

Inventories

(63 k)(1.3 m)

Accounts Payable

1.6 m3.4 m3.9 m
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

(4.9 m)(7.8 m)(11.6 m)(17.5 m)

Accounts Payable

2.9 m2.4 m3.9 m3.8 m
USDY, 2017

Revenue/Employee

54.1 k

Financial Leverage

1.3 x
Show all financial metrics

Wave Life Sciences Operating Metrics

FY, 2016

Patents Issued

27

Patents Pending

22

Phase I Trials Products

20

Phase II Trials Products

3
Show all operating metrics
Report incorrect company information